Case Number:

IPR2022-00403

Case Type:

IPR

Status:

Final Written Decision - Appealed

Petitioner:

Synthego Corporation

1. Filed: January 05, 2022 00:00

   Coverage

   1. May 17, 2023

      Synthego Gets PTAB To Ax 2 Agilent CRISPR Patents

      The Patent Trial and Appeal Board found Wednesday that two Agilent Technologies Inc. patents on the gene-editing tool CRISPR were invalid, the latest dustup in a legal fight brought by Synthego Corp. over the breakthrough technology. 

   1 other articles on this case. View all »

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login